Objective:To design and develop a battlefield first-aid simulated training system, to evaluate the application effect of the system through a quasi-experimental controlled trial, and to provide training means to support the enhancement of Chinese army's first-line treatment capability.Methods:A battlefield first-aid simulated training system was designed and developed with the guidance of the theory of "experiential learning cycle". From March to June 2023, 108 health sergeants who participated in non-academic education training from a military medical university were recruited to a quasi-experimental controlled trial and randomly divided into a control group and an experimental group, with 54 sergeants each. The control group was trained using traditional face-to-face simulation training, and the experimental group was trained using the Battlefield First-aid Simulated Training System. The differences in effects of computer simulation training and traditional face-to-face simulation training were compared, with the primary evaluation indices being the first-aid knowledge level and inferential capability of rescue on the battlefield, and the secondary evaluation indices being the self-perception and training satisfaction. The SPSS 26.0 software was used for conducting the t test, chi-square test or Fisher's exact probability test, and non-parametric test. Results:All 108 subjects completed the training and had an improvement in the knowledge level, self-perception, and inferential capability of rescue after the training ( P<0.001). The difference in the degree of improvement in the knowledge level [(19.93±8.98) vs. (16.55±10.10)] and self-perception [10.50 (7.00, 13.25) vs. 10.00 (7.00, 12.50)] was not statistically significant between the experimental group and the control group ( P>0.05), but the degree of improvement in the inferential capability of rescue of the experimental group [6.00 (5.00, 9.25)] was significantly lower than that of the control group [8.00 (7.00, 11.00)] ( P<0.05). There was no significant difference in the training satisfaction scores between the two groups ( P>0.05). Conclusions:The system has a similar training effect to traditional face-to-face simulation training, but shows a slight deficiency in the improvement in the inferential capability of rescue. It serves as a recommended training resource and format from battlefield first-aid theory learning to practical application. The system still needs to be optimized and improved in the aspects of functionality, simulation, and intellectualization in the future.

Objective:To design and develop a battlefield first-aid simulated training system, to evaluate the application effect of the system through a quasi-experimental controlled trial, and to provide training means to support the enhancement of Chinese army's first-line treatment capability.Methods:A battlefield first-aid simulated training system was designed and developed with the guidance of the theory of "experiential learning cycle". From March to June 2023, 108 health sergeants who participated in non-academic education training from a military medical university were recruited to a quasi-experimental controlled trial and randomly divided into a control group and an experimental group, with 54 sergeants each. The control group was trained using traditional face-to-face simulation training, and the experimental group was trained using the Battlefield First-aid Simulated Training System. The differences in effects of computer simulation training and traditional face-to-face simulation training were compared, with the primary evaluation indices being the first-aid knowledge level and inferential capability of rescue on the battlefield, and the secondary evaluation indices being the self-perception and training satisfaction. The SPSS 26.0 software was used for conducting the t test, chi-square test or Fisher's exact probability test, and non-parametric test. Results:All 108 subjects completed the training and had an improvement in the knowledge level, self-perception, and inferential capability of rescue after the training ( P<0.001). The difference in the degree of improvement in the knowledge level [(19.93±8.98) vs. (16.55±10.10)] and self-perception [10.50 (7.00, 13.25) vs. 10.00 (7.00, 12.50)] was not statistically significant between the experimental group and the control group ( P>0.05), but the degree of improvement in the inferential capability of rescue of the experimental group [6.00 (5.00, 9.25)] was significantly lower than that of the control group [8.00 (7.00, 11.00)] ( P<0.05). There was no significant difference in the training satisfaction scores between the two groups ( P>0.05). Conclusions:The system has a similar training effect to traditional face-to-face simulation training, but shows a slight deficiency in the improvement in the inferential capability of rescue. It serves as a recommended training resource and format from battlefield first-aid theory learning to practical application. The system still needs to be optimized and improved in the aspects of functionality, simulation, and intellectualization in the future.

Platinum antitumor drugs are widely used for clinical treatment because of their unique antitumor mechanisms, significant antitumor effects, and broad antitumor spectrum. Yet shortcomings such as toxic side effects, drug resistance and cross-resistance of platinum-based drugs have limited their further application. Platinum-intercalator conjugates possess different antitumor mechanisms from those of classic platinum drugs, and have unique advantages in overcoming the disadvantages of classic platinum antitumor drugs. The platinum-intercalator conjugates can be classified into six categories based on the different DNA-intercalator: platinum-acridine, platinum-quinoline, platinum-indole, platinum-naphthalimides, platinum-anthraquinone and platinum-based antitumor agents containing other types of intercalating groups. This article summarizes the research progress of platinum-based antitumor drugs containing DNA insertion groups in recent years.

Platinum-based anticancer drugs have been becoming one of the most effective drugs for clinical treatment of malignant tumors for its unique mechanism of action and broad range of anticancer spectrum. But, there are still several problems such as side effects, drug resistance/cross resistance and no-specific targeting, becoming obstacles to restrict its expanding of clinical application. In recent years, supramolecular chemistry drug delivery systems have been gradually concerned for their favorable safety and low toxicity. Supramolecular macrocycles-platinum complexes increased the water solubility, stability and safety of traditional platinum drugs, and have become hot focus of developing novel platinum-based anticancer drugs because of its potential targeting of tumor tissues/organs. This article concentrates in the research progress of the new drug delivery system between platinum-based anticancer drugs with three generations of macrocycles: crown ether, cyclodextrin, cucurbituril and calixarene.